i.balogun
TL2 Moderator · Tours
Contributes reviews on supplier material. Based in Tours.
Joined 29 March 2025 · last posted 16h
97 posts, newest first. Showing up to 150.
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #92 · Start Here › Welcome · 27 Jul 2026 · 0 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
GLP-1 receptor distribution: central and peripheral Replied, post #99 · Pharmacology › Receptor biology · 27 Jul 2026 · 1 like Species differences: rodent studies show the same compounds produce effects in rodents that predict human effects reasonably well for semaglutide and tirzepatide. The…
-
What a certificate commits its issuer to — one year on Replied, post #117 · Analytics › COA interpretation · 25 Jul 2026 · 3 likes post #116 is right about the mechanism and I think understates the practical bit. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the…
-
Seven-day rolling means and why weekly readings mislead Replied, post #81 · Outcomes › Progress reports · 22 Jul 2026 · 8 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
-
Seven-day rolling means and why weekly readings mislead Replied, post #64 · Outcomes › Progress reports · 19 Jul 2026 · 0 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
-
Submitting a sample: the process end to end Replied, post #72 · Sourcing › Independent verification · 10 Jul 2026 · 4 likes Janoshik Analytical: chromatographic purity and mass-spectrometric identity on submitted samples. Reports are issued with the analytical method stated and a…
-
Revisiting: How this community labels and discusses unrefereed work Replied, post #11 · Evidence › Preprints · 29 Jun 2026 · 0 likes post #10 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Revisiting: The best-written scientific paper you have read Replied, post #28 · Lounge › Off topic · 12 Jun 2026 · 9 likes Not a rules-free zone: the guidelines still apply. No phones, no Telegram, no endorsements of other communities. Just a relaxed bar for how directly the topic needs to…
-
CJC-1295 with and without DAC: what the modification does Replied, post #75 · Compounds › Secretagogues & GH axis · 4 Jun 2026 · 19 likes Evidence quality in the secretagogue literature is honestly weaker than in the incretin literature. Large randomised controlled trials are rare. Most evidence is…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #87 · Practice › Reconstitution · 3 Jun 2026 · 0 likes Picking up post #84: that is the part I would want checked first. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL…
-
Prescription requirements and telehealth models — a second dataset Replied, post #50 · Sourcing › Regulatory · 2 Jun 2026 · 5 likes I read post #48 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Why chargeback is not the safety net people assume Replied, post #16 · Sourcing › Payments · 28 May 2026 · 25 likes Currency conversion: payment in your local currency often involves a conversion fee. Paying in the supplier's native currency sometimes saves money, sometimes costs…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #3 · Compounds › Tirzepatide · 26 May 2026 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. The GIP component: GIP receptor agonism is thought to amplify the GLP-1…
-
A checklist for reading a certificate in under two minutes Replied, post #25 · Analytics › COA interpretation · 21 May 2026 · 23 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #129 · Compounds › Tirzepatide · 18 May 2026 · 23 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #109 · Practice › Interactions · 2 May 2026 · 0 likes Vitamins: most vitamins have no significant interaction. Fat-soluble vitamins (A, D, E, K) might be affected by the slowing of fat absorption during weight loss, but…
-
List price versus negotiated price versus what you pay Replied, post #99 · Access › Pricing · 16 Apr 2026 · 5 likes On post #95 — agreed on the reasoning, with one qualification. International pricing: the same compound costs very different amounts in different countries because…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #104 · Clinical › Special populations · 9 Apr 2026 · 18 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #80 · Practice › Storage & stability · 2 Apr 2026 · 2 likes Picking up post #77: that is the part I would want checked first. Published stability data applies specifically to the formulation studied, under the specific…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #2 · Evidence › Preprints · 23 Feb 2026 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #7 · Lounge › Introductions · 19 Feb 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: A page that has drifted out of date and needs a maintainer Replied, post #97 · Documentation › Wiki requests · 19 Feb 2026 · 22 likes Picking up post #94: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #39 · Practice › Dosing & titration · 17 Feb 2026 · 8 likes Picking up post #36: that is the part I would want checked first. Dose equivalence between different incretin analogues is a weak concept. The molecules differ in…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #32 · Practice › Reconstitution · 12 Feb 2026 · 0 likes Worth separating two things that post #28 runs together. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #4 · Access › Pricing · 5 Feb 2026 · 32 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #3 · Practice › Dosing & titration · 4 Feb 2026 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Constipation management, with a dietitian's contribution Replied, post #26 · Practice › Side effects · 4 Feb 2026 · 21 likes Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals all provide information that "I have nausea" does not. Posting…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #107 · Clinical › Special populations · 26 Jan 2026 · 26 likes Picking up post #104: that is the part I would want checked first. Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one… Replied, post #9 · Compounds › Oral incretins · 26 Dec 2025 · 29 likes Picking up post #6: that is the part I would want checked first. Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #34 · Clinical › Bloodwork · 22 Dec 2025 · 18 likes post #33 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #41 · Compounds › Tirzepatide · 6 Dec 2025 · 4 likes The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is a tolerance-testing dose. Confusing the purpose of a…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #22 · Sourcing › Regulatory · 3 Dec 2025 · 18 likes Picking up post #19: that is the part I would want checked first. Primary documents matter: regulatory positions are published in official documents. Reading the…
-
Availability by country, dated, with primary sources Replied, post #78 · Access › International · 27 Nov 2025 · 15 likes post #77 is right about the mechanism and I think understates the practical bit. Compounding in different countries: some countries allow pharmacy compounding under…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #89 · Compounds › Other compounds · 26 Nov 2025 · 15 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Reused chromatograms across lots: how to spot it Replied, post #4 · Analytics › COA interpretation · 19 Nov 2025 · 2 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: Aggregates and why a purity assay may miss them entirely Replied, post #23 · Analytics › Impurities & related substances · 18 Nov 2025 · 0 likes post #22 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Citation sweep results: how many references did not say what was claimed Replied, post #7 · Meta › Wiki maintenance · 17 Nov 2025 · 4 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
-
Pharmaceutical compounding rules, summarised from primary sources — a second dataset Replied, post #22 · Sourcing › Regulatory · 9 Nov 2025 · 22 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Sleep quality changes during weight loss — what changed since Replied, post #38 · Wellbeing › Sleep · 25 Oct 2025 · 6 likes Worth separating two things that post #34 runs together. Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that…
-
Thyroid function tests during substantial weight change Replied, post #108 · Clinical › Bloodwork · 24 Oct 2025 · 0 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #104 · Start Here › Welcome · 22 Oct 2025 · 3 likes Worth separating two things that post #100 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
What pooling buys you and what it destroys Replied, post #47 · Evidence › Meta-analyses · 21 Oct 2025 · 5 likes Inclusion and exclusion criteria: a meta-analysis is only as good as its inclusion criteria. If the criteria are too broad, apples and oranges get pooled. If they are…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #17 · Start Here › How to Ask · 23 Sep 2025 · 0 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Titles that describe the question, not the situation — what changed since Replied, post #20 · Start Here › How to Ask · 16 Sep 2025 · 21 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #124 · Practice › Reconstitution · 12 Sep 2025 · 29 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #127 · Data & Tools › Datasets · 11 Sep 2025 · 10 likes Privacy: if contributing data, only share data you are comfortable making permanent and public. Once posted, data is persistent.
-
Hypertension improvement and when medication needs revisiting Replied, post #48 · Clinical › Comorbidities · 8 Sep 2025 · 29 likes post #47 is right about the mechanism and I think understates the practical bit. Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed…
-
Which panel is worth repeating and which is worth ignoring Replied, post #104 · Clinical › Bloodwork · 6 Sep 2025 · 1 like Worth separating two things that post #100 runs together. Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is…
-
What a purity-only report leaves out Started this topic · Sourcing › Independent verification · 27 Aug 2025 · 4 likes What a purity-only report leaves out — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion,…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #49 · Evidence › Journal club · 26 Aug 2025 · 0 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #16 · Practice › Side effects · 25 Aug 2025 · 29 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A calculator that gives a right answer to the wrong question — does this still hold? Replied, post #7 · marked as the solution · Data & Tools › Calculators · 23 Aug 2025 · 15 likes I read post #5 twice before replying, because I had assumed the opposite. Mass error checking: enter your observed mass and theoretical mass and check whether the…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #103 · Compounds › Semaglutide · 5 Aug 2025 · 13 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #22 · Compounds › Oral incretins · 29 Jul 2025 · 4 likes Why administration conditions matter for oral semaglutide and not for injectables: the oral formulation depends on a transient pH effect in the stomach. Anything that…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #152 · Devices › Cold chain · 29 Jul 2025 · 4 likes post #151 answers the question as asked. The question underneath it is different. Light protection: avoid direct sunlight and UV exposure. Amber vials or opaque…
-
A preprint whose numbers changed substantially at publication Started this topic · Evidence › Preprints · 21 Jul 2025 · 0 likes A preprint whose numbers changed substantially at publication — setting out what I have, and where I think it stops being reliable. Session topic: SURMOUNT-2 ( Lancet ,…
-
Canadian access and provincial variation — one year on Replied, post #8 · Regional › North America · 19 Jul 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #99 · Practice › Reconstitution · 12 Jul 2025 · 0 likes post #98 answers the question as asked. The question underneath it is different. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
Why "add 2 mL" is not an instruction — a second dataset Replied, post #2 · Practice › Reconstitution · 6 Jul 2025 · 3 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
A supplier that answers analytical questions with restated claims Replied, post #109 · Sourcing › Red flags · 2 Jul 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Repeatability versus intermediate precision Replied, post #74 · Analytics › Method validation · 27 Jun 2025 · 20 likes Coming back to post #72, because the follow-up matters more than the original answer. Forced degradation studies: deliberately stress the material with acid, base,…
-
Coming back to: Official shortage notices and what they authorise Replied, post #37 · Access › Shortages · 23 Jun 2025 · 18 likes Patient advocacy during shortages: some advocacy groups advocate for patients during shortages. Knowing who they are and following their communication is useful.
-
Publishing an inconvenient result: a case study Replied, post #33 · Sourcing › Independent verification · 12 Jun 2025 · 30 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Request: a diff view for wiki revisions — the long version Replied, post #8 · Meta › Feature requests · 10 Jun 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Coming back to: Getting a referral rather than a refusal Replied, post #49 · Clinical › Prescriber conversations · 9 Jun 2025 · 0 likes post #48 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #4 · Pharmacology › Receptor biology · 3 Jun 2025 · 0 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
Journal club: SURMOUNT-4 and continuation versus withdrawal — a second dataset Replied, post #44 · Evidence › Journal club · 3 Jun 2025 · 9 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A claim built entirely on a subgroup analysis Replied, post #62 · Evidence › Study critique · 29 May 2025 · 2 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Reading a regulatory notice rather than an article about it — what changed since Replied, post #3 · Sourcing › Regulatory · 16 May 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
An emergency department visit, described afterwards Replied, post #19 · Safety › Adverse events · 10 May 2025 · 0 likes How to document: date, exact symptom or event, severity, duration, outcome, any medical attention sought. Detailed documentation is far more useful than a vague report.
-
Second pass at: Semaglutide and alcohol: what is actually documented Started this topic · Compounds › Semaglutide · 7 May 2025 · 8 likes Second pass at: Semaglutide and alcohol: what is actually documented Writing it up because I had to work it out twice and would rather nobody else did. I have seen STEP…
-
UK access routes, dated and sourced — a second dataset Replied, post #71 · Regional › UK & Ireland · 30 Apr 2025 · 5 likes Supply and shortage resilience: both UK and Ireland sourced primarily from European suppliers until recent disruptions. Domestic availability and pricing changed.
-
A report I filed that turned out to be wrong, and the correction Replied, post #18 · Sourcing › Vendor reports · 18 Apr 2025 · 6 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Carryover and the ghost peak from last week's standard Replied, post #76 · Analytics › HPLC & UHPLC · 10 Apr 2025 · 18 likes Peak purity: a diode-array detector records a spectrum at every time point. If a peak contains two co-eluting species with different spectra, the spectrum changes…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #9 · Evidence › Trials · 5 Apr 2025 · 18 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Retatrutide dose escalation in the published trials Replied, post #82 · Compounds › Retatrutide · 3 Apr 2025 · 4 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
What happens after your first post: likes, trust levels, and why none of it matters much Replied, post #15 · Start Here › Welcome · 29 Mar 2025 · 27 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #138 · Analytics › COA interpretation · 29 Mar 2025 · 5 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #50 · Evidence › Journal club · 27 Mar 2025 · 30 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #98 · Access › International · 14 Mar 2025 · 26 likes post #97 answers the question as asked. The question underneath it is different. Language barriers: if you need to communicate with a supplier, clinician, or regulator…
-
Validating a method you did not develop — does this still hold? Replied, post #65 · Analytics › Method validation · 3 Mar 2025 · 22 likes Robustness: the method gives consistent results when minor parameters vary. Tested by deliberately varying pH, temperature, flow rate, and mobile phase composition…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #70 · Compounds › Cagrilintide & amylin analogues · 23 Feb 2025 · 9 likes Picking up post #67: that is the part I would want checked first. Cagrilintide alone is discussed less than in combination because the published data is almost entirely…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #18 · Practice › Reconstitution · 17 Feb 2025 · 0 likes post #17 is right about the mechanism and I think understates the practical bit. Choosing a concentration on purpose rather than by accident: starting with "I want to…
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #72 · Evidence › Meta-analyses · 7 Feb 2025 · 30 likes This follows post #69 rather than contradicting it. Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate…
-
Scheduled maintenance and what will be unavailable Replied, post #31 · Meta › Announcements · 2 Feb 2025 · 26 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
Protein density versus volume when you cannot eat much Replied, post #34 · Nutrition & Training › Protein & intake · 29 Jan 2025 · 9 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #86 · Access › Insurance & coverage · 25 Dec 2024 · 0 likes Picking up post #83: that is the part I would want checked first. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2…
-
Persistent vomiting and the threshold for seeking help — one year on Replied, post #39 · Safety › Adverse events · 22 Dec 2024 · 7 likes Picking up post #36: that is the part I would want checked first. How to document: date, exact symptom or event, severity, duration, outcome, any medical attention…
-
Body image changing more slowly than the body Replied, post #37 · Wellbeing › Mental health · 15 Dec 2024 · 26 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Why "any advice?" is the least effective ending for a post Replied, post #77 · Start Here › How to Ask · 27 Nov 2024 · 10 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #18 · Sourcing › Red flags · 22 Nov 2024 · 6 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Transit times by route, from a logged dataset — the long version Replied, post #30 · Sourcing › Logistics · 17 Nov 2024 · 18 likes I read post #28 twice before replying, because I had assumed the opposite. Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether…
-
Criticising the method without criticising the authors Replied, post #17 · Evidence › Study critique · 14 Nov 2024 · 17 likes Confounding: in observational data, is there a third variable that explains the apparent association? In randomised data, randomisation should balance unknown…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #17 · Clinical › Prescriber conversations · 30 Oct 2024 · 0 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
-
Promotion criteria, and the one that stops most nominations Replied, post #77 · Documentation › Doc review · 4 Oct 2024 · 29 likes Picking up post #74: that is the part I would want checked first. Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #77 · Sourcing › Independent verification · 22 Sep 2024 · 18 likes I read post #75 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #38 · Compounds › Semaglutide · 6 Sep 2024 · 12 likes Coming back to post #36, because the follow-up matters more than the original answer. The mass figure differs between sources because of how the different entities…